Menopur is a drug used in assisted reproduction techniques for controlled ovarian stimulation.
It is a highly purified menotropin (human menopausal gonadotropin, HMG-hP), with follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity. Human chorionic gonadotropin (hCG), a hormone naturally present in the urine of menopausal women, is the major contributor to the LH activity of this drug.
When compared with recombinant gonadotropin products, no differences in safety, purity, or clinical efficacy have been observed.
Read the full article on: Menopur: Patient’s Manual for Ovarian Stimulation in IVF ( 73).

María Arqué
M.D., Ph.D.
Gynaecologist
Doctorate in Reproductive Medicine at the Autonomous University of Barcelona, specializing in Obstetrics and Gynecology. Dr. María Arqué has many years of experience as a Reproductive Medicine and Gynecologist Consultant and currently works as Medical Director at Fertty International.
Licence number: 080845753